Cargando…
Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability
The description more than 30 years ago of the role of de novo purine synthesis in T and B lymphocytes clonal proliferation opened the possibility for selective immunosuppression by targeting specific enzymatic pathways. Mycophenolic acid (MPA) blocks the key enzyme inosine monophosphate dehydrogenas...
Autores principales: | Golshayan, Déla, Pascual, M, Vogt, Bruno |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690976/ https://www.ncbi.nlm.nih.gov/pubmed/19753127 |
Ejemplares similares
-
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance
por: Obregon, Carolina, et al.
Publicado: (2017) -
Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry
por: Doria, Cataldo, et al.
Publicado: (2012) -
Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy
por: Hwang, Shin, et al.
Publicado: (2017) -
Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry
por: Langone, Anthony, et al.
Publicado: (2013) -
Quantitation of mycophenolic acid and metabolites by UPLC-MS/MS in renal transplant patients
por: Huang, Yun-Fen, et al.
Publicado: (2022)